Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 5Phase 2/3 2

Status

Completed 5

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Myeloid 2Plasma cell 1

Conditions

Mastocytosis 2Recurrence 1Multiple Myeloma 1Gastro-intestinal Stromal Tumours 1Gastro Intestinal Stromal Tumor 1

Interventions

Cyclophosphamide 739Cisplatin 687Gemcitabine 641Bevacizumab 615Carboplatin 604Paclitaxel 600Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 360Capecitabine 342Filgrastim 333Etoposide 328Dexamethasone 312Irinotecan 309pembrolizumab 279Leucovorin 274Cetuximab 267Cytarabine 242Erlotinib Hydrochloride 231Prednisone 227Nivolumab 227Trastuzumab 225Bortezomib 221Vincristine 220Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Completed × masitinib × Clear all
NCT00866138 2019-12-03

Masitinib in Relapse or Refractory Multiple Myeloma With t(4/14) Translocation Expressing or Not FGFR3

AB Science

Phase 2 Completed
24 enrolled
Plasma cell

Multiple Myeloma, Recurrence

NCT00831974 2018-12-11

Efficacy of AB1010 in Patients With Systemic Indolent Mastocytosis

AB Science

Phase 2 Completed
23 enrolled
Myeloid

Mastocytosis

NCT00998751 2018-12-11

Masitinib in Locally Advanced/Metastatic Gastro-intestinal Stromal Tumour (GIST)

AB Science

Phase 2 Completed
30 enrolled

Gastro-intestinal Stromal Tumours

NCT01506336 2018-12-11

Masitinib in Patients With Gastro-Intestinal Stromal Tumour Resistant to Imatinib

AB Science

Phase 2 Completed
44 enrolled

Gastro Intestinal Stromal Tumor

NCT01266369 2018-12-10

Masitinib in Patients With Mastocytosis With Handicap and Bearing the D816V Mutation

AB Science

Phase 2 Completed
21 enrolled
Myeloid

Mastocytosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡